Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - PE Ratio

The PE Ratio as of October 2026 (TTM) for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) is 17.55

According to Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 17.55. This represents a change of -14.90% compared to the average of 20.62 of the last 4 quarters.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) Historical PE Ratio (quarterly & annually)

How has 600196.SS PE Ratio performed in the past?

The mean historical PE Ratio of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. over the last ten years is 25.57. The current 17.55 PE Ratio has changed 6.76% with respect to the historical average. Over the past ten years (40 quarters), 600196.SS's PE Ratio was at its highest in in the December 2023 quarter at 161.01. The PE Ratio was at its lowest in in the December 2019 quarter at 13.04.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) Average PE Ratio

How has 600196.SS PE Ratio performed in the past?

The current PE Ratio of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) PE Ratio vs. Peers

How is 600196.SS’s PE Ratio compared to its peers?

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s PE Ratio is greater than Huadong Medicine Co., Ltd (13.32), greater than China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (12.91), less than Sichuan Kelun Pharmaceutical Co., Ltd. Class A (34.44), less than Jiangsu Hengrui Medicine Co., Ltd. (39.52), greater than Livzon Pharmaceutical Group Inc. (14.79), greater than Humanwell Healthcare (Group) Co.,Ltd. (15.23), greater than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (12.62), greater than Zhejiang NHU Company Ltd. (11.17), less than Yunnan Baiyao Group Co.,Ltd (18.18), greater than Shanghai Pharmaceuticals Holding Co., Ltd (12.88),

Build a custom stock screener for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Fosun Pharmaceutical (Group) Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shanghai Fosun Pharmaceutical (Group) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.